library(RoBMA)
library(rjags)
library(readr)
library(ggplot2)
library(dplyr)
library(tidyverse)
library(esc)
library(BayesTools)
#setwd


both_groups <- read.csv("cancer_healthy_groups.csv")

#determining standardised mean differences (SMDs)
esc_mean_sd(grp1m = both_groups$Me, grp2m = both_groups$Mc, 
            grp1sd = both_groups$Se, grp2sd = both_groups$Sc, 
            grp1n = both_groups$Ne, grp2n = both_groups$Nc)


#SMDs were manually exported to difference_effect_size.csv
meta_data = read.csv('difference_effect_size.csv')


#Comparing ITLN1 levels between healthy individuals and cancer patients in all included studies
meta_1 <- RoBMA(d=meta_data$TE, 
                se=meta_data$seTE,  
                study_names = meta_data$Author,
                seed = 2000)

summary(meta_1, type = "ensemble") 
summary(meta_1, type = "models") 
summary(meta_1, type = "diagnostics") 
summary(meta_1, type = "individual") 
  
RoBMA::interpret(meta_1)


#Sensitivity analysis - the study by Shen et al. (2016) was excluded in order to analyse its impact on the overall meta-analysis

sensitivity_data <- meta_data[-c(7), ]

meta_sens <- RoBMA(d=sensitivity_data$TE, 
                se=sensitivity_data$seTE,  
                study_names = sensitivity_data$Author,
                seed = 2000)

summary(meta_sens, type = "ensemble") 
summary(meta_sens, type = "models") 
summary(meta_sens, type = "diagnostics") 
summary(meta_sens, type = "individual") 

RoBMA::interpret(meta_sens)


#Subgroup analysis - gastrointestinal cancer patients versus healthy controls

meta_gi = meta_data %>% filter (cancer_type == "Gastrointestinal")

meta_2 <- RoBMA(d=meta_gi$TE, 
            se=meta_gi$seTE,
            study_names = meta_gi$Author,
            seed = 2000)

summary(meta_2, type = "ensemble") 
summary(meta_2, type = "models") 
summary(meta_2, type = "diagnostics") 
summary(meta_2, type = "individual") 

RoBMA::interpret(meta_2)


#Subgroup analysis - patients with urological cancer versus healthy controls

meta_uro = meta_data %>% filter (cancer_type == "Urological")

meta_3 <- RoBMA(d=meta_uro$TE, 
            se=meta_uro$seTE,
            study_names = meta_uro$Author,
            seed = 2000)

summary(meta_3, type = "ensemble") 
summary(meta_3, type = "models") 
summary(meta_3, type = "diagnostics") 
summary(meta_3, type = "individual") 

RoBMA::interpret(meta_3)


#Subgroup analysis - patients with breast cancer versus healthy controls

meta_breast = meta_data %>% filter (cancer_type == "Breast")

meta_4 <- RoBMA(d=meta_breast$TE, 
            se=meta_breast$seTE,
            study_names = meta_breast$Author,
            seed = 2000)

summary(meta_4, type = "ensemble") 
summary(meta_4, type = "models") 
summary(meta_4, type = "diagnostics") 
summary(meta_4, type = "individual") 

RoBMA::interpret(meta_4)


#Subgroup analysis - analysing only high-quality studies (identified following the quality assessment)

meta_hq = read.csv('difference_effect_sizes_hq.csv')
hq_data = meta_hq %>% filter(quality == "high") 


head(hq_data)

meta_5 <- RoBMA(d=hq_data$TE, 
            se=hq_data$seTE,
            study_names = hq_data$Author,
            seed = 2000)

summary(meta_5, type = "ensemble") 
summary(meta_5, type = "models") 
summary(meta_5, type = "diagnostics") 
summary(meta_4, type = "individual") 

RoBMA::interpret(meta_5)


#Robustness check - 3 studies measured ITLN1 levels in patients with urological cancer but did not include a (healthy) control group. 
#We want to check if adding these studies to the subgroup examining urological cancer changes the results. 
#For the control group, the average ITLN1 values from healthy individuals will be used (234ng/ml).

both_groups_robust <- read.csv("cancer_healthy_groups_robustness_check.csv")

esc_mean_sd(grp1m = both_groups_robust$Me, grp2m = both_groups_robust$Mc, 
            grp1sd = both_groups_robust$Se, grp2sd = both_groups_robust$Sc, 
            grp1n = both_groups_robust$Ne, grp2n = both_groups_robust$Nc)

#After determining SMDs for the robustness check, we exported the data manually to "difference_effect_size_robustness_check.csv". 
#Meta analysis - patients with urological cancer (with the added studies versus healthy controls 

robust_data = read.csv("difference_effect_size_robustness_check.csv")

robust_uro = robust_data %>% filter (cancer_type == "Urological")

meta_robust <- RoBMA(d=robust_uro$TE, 
                     se=robust_uro$seTE,
                     study_names = robust_uro$Author,
                     seed = 2000)

summary(meta_robust, type = "ensemble") 
summary(meta_robust, type = "models") 
summary(meta_robust, type = "diagnostics") 
summary(meta_robust, type = "individual") 

RoBMA::interpret(meta_robust)
